Drugs or disease: evaluating salivary function in RA patients.

Autor:	Torres SR; Universidade Federal do Rio de Janeiro - UFRJ, School of Dentistry and Oral Health Program, Clementino Fraga Filho University Hospital, Department of Oral Pathology and Oral Diagnostic, Rio de Janeiro, RJ, Brazil., Pedrazas CH; Universidade Federal do Rio de Janeiro - UFRJ, School of Dentistry and Oral Health Program, Clementino Fraga Filho University Hospital, Department of Oral Pathology and Oral Diagnostic, Rio de Janeiro, RJ, Brazil., Correia MP; Universidade Federal do Rio de Janeiro - UFRJ, Clementino Fraga Filho University Hospital, Department of Internal Medicine, Rio de Janeiro, RJ, Brazil., Azevedo MN; Universidade Federal do Rio de Janeiro - UFRJ, Clementino Fraga Filho University Hospital, Department of Internal Medicine, Rio de Janeiro, RJ, Brazil., Zamprogno T; Universidade Federal do Rio de Janeiro - UFRJ, School of Dentistry and Oral Health Program, Clementino Fraga Filho University Hospital, Department of Oral Pathology and Oral Diagnostic, Rio de Janeiro, RJ, Brazil., Silva A Junior; Universidade Federal do Rio de Janeiro - UFRJ, School of Dentistry and Oral Health Program, Clementino Fraga Filho University Hospital, Department of Oral Pathology and Oral Diagnostic, Rio de Janeiro, RJ, Brazil., Gonçalves LS; Universidade Estácio de Sá, Postgraduate Program in Dentistry, Rio de Janeiro, RJ, Brazil., Papi JA; Universidade Federal do Rio de Janeiro - UFRJ, Clementino Fraga Filho University Hospital, Department of Internal Medicine, Rio de Janeiro, RJ, Brazil.
Jazyk:	angličtina
Zdroj:	Brazilian oral research [Braz Oral Res] 2016 Oct 10; Vol. 30 (1), pp. e106. Date of Electronic Publication: 2016 Oct 10.
DOI:	10.1590/1807-3107BOR-2016.vol30.0106
Abstrakt:	Oral complications of RA may include temporomandibular joint disorders, mucosa alterations and symptoms of dry mouth. The aim of this study was to evaluate the salivary gland function of subjects with rheumatoid arthritis (RA) comparing it to healthy controls. Subjects with other systemic conditions known to affect salivary functions were excluded. A questionnaire was applied for the evaluation of xerostomia. Resting and chewing-stimulated salivary flow rates (SFR) were obtained under standard conditions. There were 145 subjects included of the study (104 RA and 38 controls). About 66.7% of the RA subjects and 2.4% in control group presented xerostomia. The median resting SFR were 0.24 ml/min for RA subjects and 0.40 mL/min for controls (p = 0.04). The median stimulated SFR were 1.31 mL/min for RA subjects and 1.52 ml/min for controls (p = 0.33). No significant differences were found between resting and stimulated SFR of RA subjects not using xerogenic medications and controls. There was significantly higher number of subjects presenting hyposalivation in the RA group than among controls, even when subjects using xerogenic medications were eliminated from the analysis. In conclusion, hyposalivation and xerostomia were more frequent among RA subjects not using xerogenic medication than among controls, although there were no significant differences in the median SFR between groups.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu